FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

33365511000001108: Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Sep 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100787901000001115 Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100788001000001118 Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Is a Quinagolide 25microgram tablets 3 tablet true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has AMP Quinagolide 25microgram tablets (Aspire Pharma Ltd) true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has specific active ingredient Quinagolide hydrochloride false Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quinagolide true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has basis of strength substance Quinagolide true Inferred relationship Existential restriction modifier
Quinagolide 25microgram tablets (Aspire Pharma Ltd) 3 tablet Has specific active ingredient Quinagolide hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start